Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 871 AL 885

Dopamine Transporter Imaging in Parkinson Disease: Progressive Changes and Therapeutic Modification after Anti-parkinsonian Medications

Ikeda K, Ebina J, Kawabe K, Iwasaki Y.

Intern Med. 2019 Jun 15;58(12):1665-1672. doi: 10.2169/internalmedicine.2489-18. Epub 2019 Feb 25.

α-Synuclein real-time quaking-induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism

van Rumund A, Green AJE, Fairfoul G, Esselink RAJ, Bloem BR, Verbeek MM.

Ann Neurol. 2019 May;85(5):777-781. doi: 10.1002/ana.25447. Epub 2019 Mar 25.

Concise Review: Modeling Neurodegenerative Diseases with Human Pluripotent Stem Cell-Derived Microglia

Haenseler W, Rajendran L.

Stem Cells. 2019 Jun;37(6):724-730. doi: 10.1002/stem.2995. Epub 2019 Mar 10.

Diagnostic utility of gut α-synuclein in Parkinson's disease: A systematic review and meta-analysis

Bu J, Liu J, Liu K, Wang Z.

Behav Brain Res. 2019 May 17;364:340-347. doi: 10.1016/j.bbr.2019.02.039. Epub 2019 Feb 22.

Magnetic resonance imaging-guided phase 1 trial of putaminal AADC gene therapy for Parkinson's disease

Christine CW, Bankiewicz KS, Van Laar AD, Richardson RM, Ravina B, Kells AP, Boot B, Martin AJ, Nutt J, Thompson ME, Larson PS.

Ann Neurol. 2019 May;85(5):704-714. doi: 10.1002/ana.25450. Epub 2019 Mar 26.

Disturbed homocysteine metabolism is associated with cancer

Hasan T, Arora R, Bansal AK, Bhattacharya R, Sharma GS, Singh LR.

Exp Mol Med. 2019 Feb 21;51(2):1-13. doi: 10.1038/s12276-019-0216-4.

A Comparison of Pain between Parkinson's Disease and Multiple System Atrophy: A Clinical Cross-Sectional Survey

You HY, Wu L, Yang HT, Yang C, Ding XL.

Pain Res Manag. 2019 Jan 22;2019:3150306. doi: 10.1155/2019/3150306. eCollection 2019.

Classical dopamine agonists

Horowski R, Löschmann PA.

J Neural Transm (Vienna). 2019 Apr;126(4):449-454. doi: 10.1007/s00702-019-01989-y. Epub 2019 Feb 25.

Long-Acting Injectables: Current Perspectives and Future Promise

Chaudhary K, Patel MM, Mehta PJ.

Crit Rev Ther Drug Carrier Syst. 2019;36(2):137-181. doi: 10.1615/CritRevTherDrugCarrierSyst.2018025649.

Diffuse Lewy body disease

Lin YW, Truong D.

J Neurol Sci. 2019 Apr 15;399:144-150. doi: 10.1016/j.jns.2019.02.021. Epub 2019 Feb 20.

Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease

Whone A, Luz M, Boca M, Woolley M, Mooney L, Dharia S, Broadfoot J, Cronin D, Schroers C, Barua NU, Longpre L, Barclay CL, Boiko C, Johnson GA, Fibiger HC, Harrison R, Lewis O, Pritchard G, Howell M, Irving C, Johnson D, Kinch S, Marshall C, Lawrence AD, Blinder S, Sossi V, Stoessl AJ, Skinner P, Mohr E, Gill SS.

Brain. 2019 Mar 1;142(3):512-525. doi: 10.1093/brain/awz023.

Noxious Iron-Calcium Connections in Neurodegeneration

Núñez MT, Hidalgo C.

Front Neurosci. 2019 Feb 12;13:48. doi: 10.3389/fnins.2019.00048. eCollection 2019.

A Review on the Relationship Between Sound and Movement in Sports and Rehabilitation

Schaffert N, Janzen TB, Mattes K, Thaut MH.

Front Psychol. 2019 Feb 12;10:244. doi: 10.3389/fpsyg.2019.00244. eCollection 2019.

Brain Iron Accumulation in Atypical Parkinsonian Syndromes: in vivo MRI Evidences for Distinctive Patterns

Lee JH, Lee MS.

Front Neurol. 2019 Feb 12;10:74. doi: 10.3389/fneur.2019.00074. eCollection 2019.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias